[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters to the Editor
June 2001

Statin–Alzheimer Disease Association Not Yet Proven

Arch Neurol. 2001;58(6):1022-1023. doi:

We are intrigued by the apparent negative association of 3-hydroxy-3-methylglutaryl coenzyme A inhibitor (statin) use and the presence of Alzheimer disease (AD),1 particularly since we have observed in very old patients that those with autopsy-documented AD had significantly higher levels of total and low-density lipoprotein (LDL) cholesterol than those with non-AD dementias.2,3 However, several aspects of Wolozin and colleagues' design and data presentation cloud their results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×